Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Amyotrophic lateral sclerosis; and common findings: Difficulty swallowing (dysphagia). 4 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Difficulty swallowing (dysphagia), Progressive loss of mental abilities (dementia) |
ANXA11 encodes annexin A11 (505 aa). Binds specifically to calcyclin in a calcium-dependent manner. Required for midbody formation and completion of the terminal phase of cytokinesis Highest expression in Artery Aorta (126.4 TPM) and Artery Tibial (113.4 TPM).
Amyotrophic lateral sclerosis type 23 is caused by mutations in the ANXA11 gene on chromosome 10.
ANXA11 is classified as a druggable target with score 6.5.
Genetic testing for ANXA11 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for amyotrophic lateral sclerosis type 23 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 common feature.
No clinical trials have been registered for amyotrophic lateral sclerosis type 23.
146 publications have been identified in PubMed for amyotrophic lateral sclerosis type 23. Research spans Basic Science / Preclinical (25%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (21%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 37 | 25% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Digestive system
1 |
Difficulty swallowing (dysphagia) |
Research summaries
33 |
23% |
Disease patterns and progression | 30 | 21% |
Testing and diagnosis research | 18 | 12% |
Clinical study results | 17 | 12% |
Other research | 6 | 4% |
New treatment approaches | 3 | 2% |
Patient case studies | 2 | 1% |
Grassano M (2026). [PMID: 41665049](https://pubmed.ncbi.nlm.nih.gov/41665049/). *Ann Neurol*. [Epidemiology / Natural History]
Cudkowicz M (2026). [PMID: 41837970](https://pubmed.ncbi.nlm.nih.gov/41837970/). *JAMA Neurol*. [Clinical Trial Publication]
Baindoor S (2026). [PMID: 41175163](https://pubmed.ncbi.nlm.nih.gov/41175163/). *Amyotroph Lateral Scler Frontotemporal Degener*. [Basic Science / Preclinical]
Zheng M (2026). [PMID: 41987206](https://pubmed.ncbi.nlm.nih.gov/41987206/). *J Neuroinflammation*. [Review / Meta-Analysis]
Gonçalves F (2026). [PMID: 41738691](https://pubmed.ncbi.nlm.nih.gov/41738691/). *Palliat Support Care*. [Epidemiology / Natural History]
Kaji R (2026). [PMID: 41475066](https://pubmed.ncbi.nlm.nih.gov/41475066/). *J Neurol Sci*. [Clinical Trial Publication]
Tarutani A (2026). [PMID: 41486180](https://pubmed.ncbi.nlm.nih.gov/41486180/). *Acta neuropathologica communications*. [Basic Science / Preclinical]
Naumann M (2026). [PMID: 41603250](https://pubmed.ncbi.nlm.nih.gov/41603250/). *Advanced science (Weinheim, Baden-Wurttemberg, Germany)*. [Diagnostic / Biomarker]
Keerthipriya MS (2026). [PMID: 41511639](https://pubmed.ncbi.nlm.nih.gov/41511639/). *J Neurol*. [Epidemiology / Natural History]
Moens TG (2026). [PMID: 41832182](https://pubmed.ncbi.nlm.nih.gov/41832182/). *Cell Death Dis*. [Basic Science / Preclinical]